CSF2 and Sepsis: An in vivo and in vitro study (103) demonstrated that recombinant GM-CSF can increase the expression of IL-1β in polymorphonuclear neutrophils, thereby enhancing their bactericidal ability and improving the prognosis of secondary Pseudomonas aeruginosa pneumonia induced by sepsis.